About Mati Therapeutics
Mati Therapeutics is a private company based in Austin, Texas. It has reported $14,192,540 raised in six offerings on Form D since April 2013. Its chief executive is Robert Butchofsky.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 30, 2025 | Oct 8, 2025 | $9,867,695of $10.5M target | 13 | $759K | Equity, revenue shareRule 506(b) | Form D ↗ |
| Sep 12, 2025 | Sep 23, 2025amended Jul 2, 2026 | $2,649,815of $4.8M target | 2 | $1.3M | Equity, Revenue ShareRule 506(b) | Form D/A ↗1 earlier filing |
| May 11, 2019 | May 24, 2019 | $165,030of $1.5M target | 2 | $82,515 | EquityRule 506(b) | Form D ↗ |
| Oct 1, 2018 | Oct 16, 2018 | $50,000of $1.2M target | 1 | $50,000 | EquityRule 506(b) | Form D ↗ |
| Sep 30, 2014 | Oct 10, 2014 | $150,000of $13.8M target | 2 | $75,000 | EquityRule 506(c) | Form D ↗ |
| Apr 3, 2013 | Apr 15, 2013 | $1,310,000of $10.0M target | 13 | $100K | Equity06 | Form D ↗ |
| Total, six offerings | $14,192,540 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Mati Therapeutics's Form D filed Oct 8, 2025.
LL
Linda Lupini
Director
JM
Jim Mazzo
Director
KJ
Ken Jones
Director
DF
Dave Fellows
Director
Cameron Nelson
Chief Financial Officer
PM
Peter McDonnell
Director
Christopher Muller
Chief Operating Officer and director
JI
Joseph Tortorice III
Director
Earlier filings also listed Deepank Utkhede (director, last listed Oct 2025) and Deepank Utkede (executive officer and director, last listed Oct 2014).